about
CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosisEvidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALSAnalysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTDA ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosisImpairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron diseasePathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosisKetogenic diet in neuromuscular and neurodegenerative diseasesWhat we truly know about occupation as a risk factor for ALS: A critical and systematic reviewAmyotrophic lateral sclerosis: considerations on diagnostic criteriaThe multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosisTreatment for fatigue in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND)Creatine for amyotrophic lateral sclerosis/motor neuron diseaseRepetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron diseaseRepetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron diseaseTreatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosisCreatine for amyotrophic lateral sclerosis/motor neuron diseaseRepetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron diseaseTreatment for sialorrhea in people with motor neuron disease or amyotrophic lateral sclerosisMinocycline for amyotrophic lateral sclerosis or motor neuron diseaseExpression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosisXIAP: cell death regulation meets copper homeostasisOlesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosisClinical and experimental applications of sodium phenylbutyrateChromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association studyWhole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosisExome sequencing reveals VCP mutations as a cause of familial ALSDecreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice modelA hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTDNitric oxide and peroxynitrite in health and diseaseThe endocannabinoid system as an emerging target of pharmacotherapyMisfolded CuZnSOD and amyotrophic lateral sclerosisALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomesLaryngeal dysfunction in Amyotrophic Lateral Sclerosis: a review and case report.From animal models to human disease: a genetic approach for personalized medicine in ALSPain in Neurodegenerative Disease: Current Knowledge and Future PerspectivesImpaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron DegenerationA comprehensive review of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis: New Perpectives and UpdateResveratrol: A Focus on Several Neurodegenerative DiseasesThe Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases
P2860
Q21132045-AFEB92CA-2EC9-4114-BAC9-0A2B6A41A4FEQ21144409-7160DEEA-FE7C-401B-94AC-7B7F1B035903Q21261387-BBE15495-467A-404B-B3F4-454E6B447D5CQ21262053-306501D0-6730-4DFD-BFC7-C18E8D6462A3Q21262978-97DC51C1-63A6-41B0-8D0E-7FB30AF0BF0CQ21266563-69BD8FF8-A32D-436F-B563-368E22851A16Q21284703-ECEE8B9E-26C2-4845-8B15-0E67F2E0BBE4Q22305680-7C647C7D-AE52-47C0-A149-6BAC3A3AF652Q22305918-A623ED99-0450-4225-894A-612CE834D553Q23917508-8F4E411D-9F11-4597-B79A-2FD88BAA5BB4Q24199017-9BDEDBF9-5B07-465C-90A9-860136C37BF6Q24202577-196789C1-C56E-4BFB-9306-901601F43FECQ24202639-A7E5797F-13F6-479D-A04D-20EEBE4F72DAQ24234300-72125169-A425-45E9-99D0-1D128DF331CEQ24234650-8D122B01-E921-45B7-88C9-871435F7855EQ24234800-87047DE5-48A0-4320-93D4-4A7FC225F9FDQ24235041-2E28BCB5-95D2-4767-B219-ED77EB7B6CF7Q24243640-419A052B-58F8-40B0-8175-C17A800E7F46Q24243793-F8AA1DA3-6873-439F-A645-70464E20A290Q24295307-C954EFA1-0149-42E5-9C56-0F57708CD193Q24300814-752EAF87-FF9C-4852-BE56-8DE9C493DEFCQ24596378-3951A99C-6940-4ACB-B0C4-B25CD9EBA2E6Q24613511-6E4CACFF-978E-41DC-BD05-0139900B24CCQ24622472-429C7F77-BCBB-473C-B027-39F112FF7A5AQ24623830-BF922C6D-F159-4538-AFFF-962499B877F9Q24631513-9099879C-2524-4625-86F7-13DF3FD71661Q24632133-ABEDD8EC-F45E-495E-AF64-7E9063771240Q24634583-90A774B3-1EA3-471E-8F32-9D3EE95EC18FQ24645400-D53AD6CE-E2FD-4817-BB34-9B5FC617035BQ24648473-9BC83867-316B-49D4-9FC9-68B911537ACBQ24683677-66808C16-C7FF-4194-9681-F988E7D31702Q24792140-6255A0CB-0F46-401B-A3ED-C9EB066EE22BQ24795457-6DA19FC1-78C3-4D5A-A3DB-1C1D3B5BE89DQ26741250-460FBC8B-957C-4473-B729-72ABEE34DC20Q26745618-E1F1D7D6-0B1A-4DC9-B568-F330F352A537Q26766040-E46E3B24-ED14-4191-A09A-656CE535A23EQ26775401-EC3B6B96-CC6A-4132-825F-BD576AD79A3EQ26781051-E4B214AB-A7B8-44A7-8677-BC19BAA7A6B1Q26800952-87D49998-55FB-4A16-8168-35902CFA1FDDQ26822972-C40261CC-6F52-4B7D-9FAB-E7A890EEA45D
P2860
description
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Mai 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article from 2001
@en
videnskabelig article fra 2001
@da
wetenschappelijk artikel (gepubliceerd op 2001/05/31)
@nl
наукова стаття, опублікована в травні 2001
@uk
مقالة علمية (نشرت في 31-5-2001)
@ar
name
Amyotrophic lateral sclerosis
@ast
Amyotrophic lateral sclerosis
@da
Amyotrophic lateral sclerosis
@de
Amyotrophic lateral sclerosis
@en
Amyotrophic lateral sclerosis
@eo
Amyotrophic lateral sclerosis
@fo
Amyotrophic lateral sclerosis
@fr
Amyotrophic lateral sclerosis
@is
Amyotrophic lateral sclerosis
@kl
Amyotrophic lateral sclerosis
@nb
type
label
Amyotrophic lateral sclerosis
@ast
Amyotrophic lateral sclerosis
@da
Amyotrophic lateral sclerosis
@de
Amyotrophic lateral sclerosis
@en
Amyotrophic lateral sclerosis
@eo
Amyotrophic lateral sclerosis
@fo
Amyotrophic lateral sclerosis
@fr
Amyotrophic lateral sclerosis
@is
Amyotrophic lateral sclerosis
@kl
Amyotrophic lateral sclerosis
@nb
prefLabel
Amyotrophic lateral sclerosis
@ast
Amyotrophic lateral sclerosis
@da
Amyotrophic lateral sclerosis
@de
Amyotrophic lateral sclerosis
@en
Amyotrophic lateral sclerosis
@eo
Amyotrophic lateral sclerosis
@fo
Amyotrophic lateral sclerosis
@fr
Amyotrophic lateral sclerosis
@is
Amyotrophic lateral sclerosis
@kl
Amyotrophic lateral sclerosis
@nb
P3181
P1476
Amyotrophic lateral sclerosis
@en
P2093
Rowland LP
Shneider NA
P304
P3181
P356
10.1056/NEJM200105313442207
P407
P577
2001-05-31T00:00:00Z